Global Anti-microbial/Anti-fungal Tests Market is Anticipated to Grow to a Value of USD 4.5 Billion by 2032 At a compound annual growth rate (CAGR) of 5.7%

The market for antimicrobial and antifungal testing is anticipated to grow to a value of USD 2.5 billion by the end of 2022. At a compound annual growth rate (CAGR) of 5.7%, the market is expected to reach a value of around USD 4.5 billion by 2032. With a nearly 53.5% market share in 2021, molecular-based tests dominated the market by test type.

The researcher has been effectively using microorganism screening to develop new antibiotics for many years. Antibiotics are frequently produced by bacteria and fungi. Agriculture is one of the many industries that uses bacteria. An antimicrobial is a chemical that either kills or stops the growth of microorganisms in the pharmaceutical and veterinary sectors.

In these situations, bacteria are used against fungus, while antibiotics are used against antifungals. Antimicrobial prophylaxis employs antimicrobial medications to avoid infection, while antimicrobial chemotherapy uses antimicrobial medications to fight infection. For illnesses that are challenging to treat, antimicrobial susceptibility testing can assist doctors in selecting the appropriate medication and dosage.

Competitive Landscape

With several competitors in the anti-microbial/anti-fungal tests market, the overall market is fragmented. To meet consumer demand and expand their customer base, these companies are implementing methods such as mergers and acquisitions, partnerships and collaborations, and new product launches.

• In July 2022, Roche announced that Elecsys HCV Duo immunoassay is now available in countries that accept the CE Mark. Elecsys HCV Duo is the only immunoassay on the market that can determine hepatitis C virus (HCV) antigen and antibody status from a single human plasma or serum sample.
• In June 2022, Meridian Bioscience, Inc., a global leader in diagnostic testing solutions and life science raw materials, introduced two new sample-specific master mixes, Lyo-Ready Direct DNA qPCR Stool Mix and Lyo-Ready Direct RNA/DNA qPCR Stool Mix. These novel master mixes increase the molecular detection of DNA and RNA from crude faecal materials while allowing diagnostic procedures to be room temperature stabilised.

Key Companies Profiled

• Abbott Laboratories
• bioMérieux SA
• Bio-Rad Laboratories Inc
• Bruker Corporation
• Danaher Corporation
• Erba Mannheim
• F. Hoffmann-La Roche AG
• Luminex Corporation
• Meridian Bioscience Inc
• Norgen Biotek Corp
• Omega Diagnostics Group Plc
• Qiagen N.V
• Quidel Corporation
• Thermo Fisher Scientific Inc

Get the Comprehensive Full Report Now

Key Market Segments Covered in Anti-microbial/Anti-fungal Tests Industry Research

By Tests Type:

• Molecular Based Tests
  • PCR Test
  • DNA Microarray
• Phenotypic Resistance Tests
• Complex Test Panels
• Mass Spectrometry
• Rapid Diagnostic Tests
  • E-Test Antibiotic/Antifungal Strips
  • Biosensor Platforms

By Infection Type:

• Antimicrobial Resistance
  • Methicillin-Resistant Staphylococcus Aureus
  • Vancomycin-Resistant Enterococcus
  • Multi-Drug-Resistant Mycobacterium tuberculosis
  • Carbapenem-Resistant Enterobacteriaceae gut bacteria
• Microbial Infection
• Antifungal Resistance
  • Candida infections
  • Aspergillus infection
  • Fusariosis
  • Others
• Fungal Infection

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Community Health Centers
• Reference Laboratories

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube